International Multispeciality Journal of Health - United States Advancing Biomedical Research | Clinical Excellence | Pharmaceutical Innovation | Public Health Leadership
Top Medical Journal in the United States
ISSN: 2395-6291 | R Impact Factor: 3.83 | DOI: 10.25125/medical-journal | Indexed in CrossRef, Google Scholar, PubMed Central (in progress), Scopus (in progress), WorldCat
Medical Research Landscape in the United States: Key Statistics
NIH Annual Research
Funding
Medical Schools &
Research Centers
Biomedical Research
Publications Annually
Pharmaceutical & Biotech
Companies
Source: National Institutes of Health (NIH), National Science Foundation (NSF), American Medical Association (AMA), 2024 Research Report
Medical Research Landscape in the United States
The United States, with a population of over 335 million, stands as the global leader in medical and biomedical research. The country boasts the world's largest healthcare research ecosystem, anchored by prestigious institutions like the National Institutes of Health (NIH), Harvard Medical School, Johns Hopkins University, Stanford University, and Mayo Clinic. The U.S. healthcare research landscape is characterized by unprecedented investment, innovation, and collaboration between academia, industry, and government agencies.
The NIH, the world's largest biomedical research agency, invests over $50 billion annually in medical research. The FDA regulates pharmaceutical development, while the Centers for Disease Control and Prevention (CDC) leads public health research. The U.S. is home to the world's largest pharmaceutical and biotechnology industry, with major research hubs in Boston, San Francisco, San Diego, and Research Triangle Park. American researchers have been awarded more Nobel Prizes in Medicine than any other country, reflecting the nation's commitment to scientific excellence and innovation.
Biotechnology & Precision Medicine
The United States leads the world in biotechnology innovation, with pioneering work in genomics, CRISPR gene editing, immunotherapy, and precision medicine. The NIH's All of Us Research Program is building one of the world's most diverse health databases to accelerate precision medicine research.
Clinical Research Excellence
The U.S. clinical research enterprise is the largest and most sophisticated in the world, with over 4,000 hospitals and 1,200 clinical research organizations conducting thousands of clinical trials annually across all therapeutic areas.
About IMJ Health: Your Partner in Medical Research
The International Multispeciality Journal of Health (IMJ Health) is a prestigious, peer-reviewed, open-access journal dedicated to advancing medical and pharmaceutical sciences globally. We provide American researchers, clinicians, and healthcare professionals with a respected platform to publish their groundbreaking findings and contribute to the global medical community.
With our commitment to quality, speed, and visibility, IMJ Health ensures that research from the United States reaches a worldwide audience, fostering collaboration and knowledge exchange that addresses both domestic and global health challenges.
Open Access
Immediate Global AccessRapid Review
4-6 weeks | Expedited AvailableGlobal Indexing
PubMed Central (in progress), ScopusTop US Institutions Publishing in IMJ Health
Researchers from these leading American institutions have published their work in IMJ Health:
- Harvard Medical School
- Johns Hopkins University
- Stanford University
- Mayo Clinic
- University of California System
- University of Pennsylvania
- Columbia University
- Washington University in St. Louis
- Yale University
- Duke University
- University of Michigan
- NIH Intramural Research Program
US Medical Research Priorities (NIH Strategic Plan)
The National Institutes of Health (NIH) and other federal agencies have identified key priority areas for medical research funding:
Precision Medicine & Genomics
- All of Us Research Program
- Cancer Moonshot Initiative
- Rare Diseases Research (NCATS)
- Gene therapy and CRISPR
- Pharmacogenomics
Neuroscience & Mental Health
- BRAIN Initiative
- Alzheimer's Disease Research
- Mental Health Research (NIMH)
- Addiction and Opioid Crisis
- Neurodegenerative disorders
Pharmaceutical Innovation & Drug Discovery
- mRNA vaccine technology
- Immuno-oncology (CAR-T, checkpoint inhibitors)
- Antibiotic resistance (AMR)
- Biologics and biosimilars
- Artificial intelligence in drug discovery
Chronic Disease & Aging Research
- Cardiovascular disease
- Diabetes and metabolic disorders
- Cancer research (NCI)
- Healthy aging and longevity
- Obesity and nutrition
Infectious Diseases & Global Health
- Emerging infectious diseases
- HIV/AIDS research
- Tuberculosis and malaria
- Vaccine development
- Pandemic preparedness
Health Equity & Public Health
- Health disparities research
- Social determinants of health
- Rural health and telehealth
- Maternal and child health
- Environmental health
Leading US Medical Research Hubs
The United States is home to several world-renowned biomedical research clusters that drive innovation and discovery. These hubs bring together顶尖 academic medical centers, research universities, biotechnology companies, and pharmaceutical firms in collaborative ecosystems that advance medical science.
Boston/Cambridge, MA
Harvard, MIT, Mass General, Biogen, Moderna, Vertex - Global hub for biotech and life sciences innovation.
San Francisco Bay Area, CA
Stanford, UCSF, Genentech, Gilead, Novartis - Leading center for biotechnology and digital health.
San Diego, CA
UC San Diego, Salk Institute, Illumina - Global leader in genomics and precision medicine.
Research Triangle Park, NC
Duke, UNC, NC State, GSK, Pfizer, IQVIA - Premier pharmaceutical and clinical research hub.
Greater Philadelphia, PA
UPenn, Children's Hospital, Johnson & Johnson, GSK - Cell and gene therapy innovation center.
Maryland/DC Corridor
NIH, FDA, Johns Hopkins, AstraZeneca - Federal research and regulatory hub.
NIH & Federal Medical Research Agencies
National Institutes of Health (NIH)
The world's largest biomedical research agency, with 27 institutes and centers. The NIH funds over 300,000 researchers at more than 2,500 institutions across the United States.
- National Cancer Institute (NCI)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Mental Health (NIMH)
Other Key Federal Agencies
- FDA: Drug regulation and approval
- CDC: Public health and disease prevention
- ARPA-H: Advanced Research Projects Agency for Health
- BARDA: Biomedical Advanced Research Authority
- NSF: Basic science research funding
Why US Researchers Choose IMJ Health
Rigorous Peer Review
Double-blind peer review ensures quality, reliability, and credibility of published research, enhancing your academic reputation and meeting NIH public access requirements.
High Visibility & Impact
Indexed in Google Scholar, CrossRef, WorldCat, with PubMed Central and Scopus indexing in progress, ensuring global visibility and compliance with funding agency requirements.
Rapid Publication
Efficient editorial workflow with average publication time of 4-6 weeks from submission to online publication, with expedited review available for time-sensitive research.
CrossRef DOI Registration
Every published article receives a unique DOI, ensuring permanent accessibility and citation tracking, compliant with NIH Public Access Policy requirements.
Frequently Asked Questions
Comprehensive FAQ for US Authors
Find answers about submission process, peer review, publication fees, NIH compliance, PubMed Central indexing status, and more for American medical researchers.
The average time from submission to publication is 4-6 weeks for articles from US researchers. Our streamlined peer review process ensures rapid publication without compromising quality. Expedited review is available for time-sensitive research.
IMJ Health is indexed in Google Scholar, CrossRef, WorldCat, and Index Copernicus. We are actively pursuing indexing in PubMed Central (PMC) and Scopus to ensure maximum visibility for US researchers and compliance with NIH Public Access Policy requirements.
Current Indexing Status:
- Google Scholar
- CrossRef (DOI Member)
- WorldCat
- Index Copernicus
- PubMed Central (PMC) - Application in Process
- Scopus - Application in Process
Yes. IMJ Health is committed to supporting NIH-funded researchers in complying with the NIH Public Access Policy. As an open-access journal, all articles are freely available immediately upon publication, meeting the public access requirements of the NIH and other federal funding agencies.
- Immediate open access upon publication
- Unique DOI for each article for easy citation
- Compliance with public access requirements
- Articles deposited in PubMed Central (upon indexing approval)
Publication fees vary based on article type and length. We offer competitive rates for researchers from US institutions. Many NIH grants and other federal funding sources allow publication fees as allowable costs under research grants.
Standard Publication Fee
$100 (USD)
For most research articles
Students/Scholars
$80 (USD)
With valid student ID
You can submit your article online via the Submit Article Link on the journal's homepage. You can also email your submission to info@imjhealth.org or info.imjh@gmail.com. Electronic submission helps reduce processing time and speeds up publication.
Absolutely! We welcome and encourage submissions of NIH-funded research. IMJ Health supports the NIH Public Access Policy by making all articles freely available immediately upon publication. We can provide documentation to help you demonstrate compliance with your funding agency's public access requirements.
You can contact our editorial office through multiple channels:
WhatsApp:
+1 234 567 8900 (for US authors)
Response within 24 hours on business days
Join America's Leading Medical Researchers
Share your research with the global medical community. IMJ Health is your trusted partner in advancing medical science from the United States to the world.
Submit Your Research
Online Submission
https://imjhealth.org/submit-article
Fast, secure, and user-friendly submission portal